Physician profile
Robert J Price
NPI 1326017989
$4,258.18
in general payments reported to CMS, 2019-2025
16 companies · $1,260 in 2025
The $1,260 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $569 · 2020: $81.64 · 2021: $236 · 2022: $765 · 2023: $817 · 2024: $529 · 2025: $1,260.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,606.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,606.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $977.15 | 2019-2025 | Dragonfly Opstar, Diamondback Coronary |
| Boston Scientific Corporation | $658.86 | 2019-2025 | General - Therapies, Avvigo Guidance System, Watchman Flx |
| Abiomed | $591.02 | 2022-2025 | Impella |
| Shockwave Medical, INC | $474.56 | 2022-2025 | |
| Edwards Lifesciences Corporation | $351.85 | 2019-2023 | Sapien 3 Ultra Resilia |
| Biotronik INC. | $230.49 | 2023-2024 | Orsiro Mission, Pk Papyrus |
| Medtronic, INC. | $202.57 | 2025 | Onyx Frontier |
| Asahi Intecc USA, INC. | $199.61 | 2025 | Asahi Coronary Wires |
| Teleflex LLC | $165.45 | 2023 | Guideliner |
| Livanova USA, INC. | $142.57 | 2022 | |
| Philips North America LLC | $121.99 | 2019 | |
| Medtronic Vascular, INC. | $81.64 | 2020 | |
| Sanofi-Aventis U.S. LLC | $17.71 | 2019 | |
| Janssen Pharmaceuticals, INC | $15.70 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $14.56 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $12.45 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Price listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.